DUAL INHIBITION OF HUMAN FACTOR BETA ACTIVITY OF THE COMPLEMENT ALTERNATIVE PATHWAY BY GUINEA PIG AND HUMAN SERA: EFFECT OF HEATING AND OF COMPLEMENT ACTIVATIONLAMBRE C.1980; IMMUNOL. LETT.; NLD; DA. 1980; VOL. 2; NO 2; PP. 81-86; BIBL. 18 REF.Article

Le système du complément = The complement systemLAMBRE, C.Allergie et immunologie (Paris). 1993, Vol 25, Num 7, pp 272-279, issn 0397-9148, 6 p.Article

Les risques liés aux contaminants chimiques dans le lait maternel = Chemical contamination of breast milk: risksLAMBRE, C.Journal de pédiatrie et de puériculture. 2002, Vol 15, Num 1, pp 11-16, issn 0987-7983Article

Les risques liés aux contaminants chimiques dans le lait maternelLAMBRE, C.Journal de pédiatrie et de puériculture. 2002, Vol 15, Num 1, pp 11-16, issn 0987-7983Article

ABILITY TO ACTIVATE THE ALTERNATIVE COMPLEMENT PATHWAY ACQUIRED BY HUMAN AND GUINEA-PIG ERYTHROCYTES AFTER CONTACT WITH INFLUENZA VIRUSLAMBRE C; THIBON M.1980; ANN. IMMUNOL.; FRA; DA. 1980; VOL. 131; NO 2; PP. 213-221; BIBL. 17 REF.Article

ACTION DE L'HYPEROXIE SUR L'ACTIVITE HEMOLYTIQUE DU SYSTEME DU COMPLEMENT.THOMAS JA; LAMBRE C; DELARBRE C et al.1977; C.R. ACAD. SCI., D; FR.; DA. 1977; VOL. 284; NO 2; PP. 131-136; ABS. ANGL.; BIBL. 16 REF.Article

ROLE DE L'ERGASTOPLASME DANS LE CYCLE MORPHOGENETIQUE DU VIRUS D'UNE SOUCHE DE MYXOMATOSETHOMAS JA; HENRY M; HOLLANDE E et al.1972; C.R. ACAD. SCI., D; FR.; DA. 1972; VOL. 275; NO 25; PP. 3047-3052; BIBL. 8 REF.Serial Issue

Ozone et système immunitaire = Ozone and the immune systemLACROIX, G; LAMBRE, C.Revue des maladies respiratoires. 1998, Vol 15, Num 6, pp 699-711, issn 0761-8425Article

Évaluation expérimentale de la toxicité des fibres de laines minérales synthétiques = Experimental evaluation of synthetic mineral wool toxicityLAMBRE, C.Revue de médecine du travail. 1998, Vol 25, Num 4, pp 216-223, issn 0300-0559Conference Paper

Définitions ― champs d'application ― Mécanismes biologiques = Definitions―Application fields―biological mecanismsLAMBRE, C.Revue de médecine du travail. 1997, Vol 24, Num 2, pp 64-67, issn 0300-0559Conference Paper

An enzyme immunoassay for auto-antibodies to keratin in normal human serum and in pleural fluids from patients with various malignant or non-malignant lung diseasesLAMBRE, C. R; NAIMA ALAOUI-SLIMANI; BIGNON, J et al.Journal of clinical & laboratory immunology. 1986, Vol 20, Num 4, pp 171-176, issn 0141-2760Article

An enzyme-linked lectin assay for sialidaseLAMBRE, C. R; TERZIDIS, H; GREFFARD, A et al.Clinica chimica acta. 1991, Vol 198, Num 3, pp 183-193, issn 0009-8981Article

Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substratesLAMBRE, C. R; TERZIDIS, H; GREFFARD, A et al.Journal of immunological methods. 1990, Vol 135, Num 1-2, pp 49-57, issn 0022-1759Article

Determination of the complement component C2 by ELISA in human serum and bronchoalveolar lavage fluidsGREFFARD, A; BOURGARIT, J-J; LE MAHO, S et al.Immunology letters. 1987, Vol 15, Num 2, pp 145-151, issn 0165-2478Article

Determination of the sialic acid linkage specificity of sialidases using lectins in a solid phase assayROGERIEUX, F; BELAISE, M; TERZIDIS-TRANBELSI, H et al.Analytical biochemistry. 1993, Vol 211, Num 2, pp 200-204, issn 0003-2697Article

Sialidase in the Guinea pig pulmonary parenchyma. Increased activity in the cytosolic and microsomal subcellular fractions after stimulation with Bacillus calmette GuérinTERZIDIS-TRABELSI, H; PILATTE, Y; GREFFARD, A et al.Biological chemistry Hoppe-Seyler. 1991, Vol 372, Num 6, pp 437-442, issn 0177-3593Article

Activation of the hsp 70 promoter by environmental inorganic and organic chemicals : relationships with cytotoxicity and lipophilicityAÏT-AÏSSA, S; PORCHER, J.-M; ARRIGO, A.-P et al.Toxicology (Amsterdam). 2000, Vol 145, Num 2-3, pp 147-157, issn 0300-483XArticle

Sialidase activity and antibodies to sialidase-treated autologus erythrocytes in bronchoalveolar lavages from patients with idiopathic pulmonary fibrosis or sarcoidosisLAMBRE, C. R; PILATTE, Y; LE MAHO, S et al.Clinical and experimental immunology (Print). 1988, Vol 73, Num 2, pp 230-235, issn 0009-9104Article

Vérification et validation des conditions expérimentales optimales pour l'incinération des déchets de médicaments anticancéreux = Verification and validation of best experimental conditions for incineration of antitumoral drug wastesBisson, M; Lambré, C; Gabarda, M.D et al.1998, 2Vol, [75] pReport

Effects of neuraminidase on airway reactivity in the guinea pigJARREAU, P.-H; HARF, A; LEVAME, M et al.The American review of respiratory disease. 1992, Vol 145, Num 4, pp 906-910, issn 0003-0805, 1Article

Elimination par incinération des déchets liés à l'utilisation de médicaments anticancéreux = Incineration of anticarcinogenic drugsBisson, M; Dujardin, R; Rose, M et al.1995, 3Vol, [330] pReport

Use of transepithelial electrical resistance in the study of pentachlorophenol toxicityVELARDE, G; AIT-AISSA, S; GILLET, C et al.Toxicology in vitro. 1999, Vol 13, Num 4-5, pp 723-727, issn 0887-2333Conference Paper

Induction of the hsp70 gene promoter by various anticancer drugsAÏT-AÏSSA, S; PORCHER, J.-M; KRETZ-REMY, C et al.Toxicology in vitro. 1999, Vol 13, Num 4-5, pp 651-655, issn 0887-2333Conference Paper

In vitro tests for respiratory toxicity : The report and recommendations of ECVAM Workshop 18LAMBRE, C. R; AUFDERHEIDE, M; NETTESHEIM, P et al.ATLA. Alternatives to laboratory animals. 1996, Vol 24, Num 5, pp 671-681, issn 0261-1929Article